RS
ANVS icon

R Squared’s Annovis Bio ANVS Stock Holding History

R Squared’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.5K Buy
+17,698
New +$28.8K 0.01% 488
2025
Q1 		– Sell
-1,520
Closed -$7.65K – 358
2024
Q4 		$7.65K Buy
+1,520
New +$11K 0.01% 1223

Other funds holding ANVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $107M AUM 11.17% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return
Gill Capital Partners
Gill Capital Partners Denver, Colorado $366M AUM 12.21% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
Quadcap Wealth Management
Quadcap Wealth Management Frisco, Texas $1.06B AUM 19.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
RKL Wealth Management
RKL Wealth Management Lancaster, Pennsylvania $1.26B AUM 18.95% 1-Year Est. Return

R Squared's ANVS Position: Q3 2026 in Review

R Squared opened a new position in Annovis Bio (ANVS) in Q3 2026: 17,698 shares worth $22.5K. The stake represents 0.01% of the portfolio and ranks #488 among its holdings. This is a return to the name: R Squared previously reported a position in ANVS as recently as Q4 2024.

R Squared first reported a position in ANVS in Q4 2024 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • R Squared held 17,698 shares of Annovis Bio worth $22.5K as of Q3 2026.
  • Annovis Bio was a new R Squared position in Q3 2026.
  • Annovis Bio made up 0.01% of R Squared's portfolio in Q3 2026, its #488 holding.
  • R Squared first reported a position in Annovis Bio in Q4 2024 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on R Squared's 13F filing for Q3 2026, filed 6 Nov 2026.